Segura, AG, Martinez-Pinteno, A, Gasso, P, Rodriguez, N, Bioque, M, Cuesta, MJ, Gonzalez-Penas, J, Garcia-Rizo, C, Lobo, A, Gonzalez-Pinto, A, Garcia-Alcon, A, Roldan, A, Vista, E, Castro-Fornieles, J, Mane, A, Saiz, J, Bernardo, M, Mas, S. Metabolic polygenic risk scores effect on antipsychotic-induced metabolic dysregulation: A longitudinal study in a first episode psychosis cohort. SCHIZOPHRENIA RESEARCH. 2022; 244DOI:10.1016/j.schres.2022.05.021. PMID:35659654. IF:4.500(Q2/4D).

Alvear, D, Soler, J, Cebolla, A. Meditators' Non-academic Definition of Mindfulness. Mindfulness. 2022; 13(6)DOI:10.1007/s12671-022-01899-3. PMID:35634214. IF:3.600(Q2/4D).

Bioque, M, Mezquida, G, Amoretti, S, Garcia-Rizo, C, Lopez-Ilundain, JM, Diaz-Caneja, CM, Zorrilla, I, Mane, A, Rodriguez-Jimenez, R, Corripio, I, Pomarol-Clotet, E, Ibanez, A, Usall, J, Contreras, F, Mas, S, Vazquez-Bourgon, J, Cuesta, MJ, Parellada, M, Gonzalez-Pinto, A, Hidalgo-Figueroa, M, Bernardo, M. Clinical and treatment predictors of relapse during a three-year follow-up of a cohort of first episodes of schizophrenia. SCHIZOPHRENIA RESEARCH. 2022; 243DOI:10.1016/j.schres.2022.02.026. PMID:35231832. IF:4.500(Q2/4D).

Porta-Casteras, D, Cano, M, Steward, T, Andero, R, Cardoner, N. The pituitary adenylate cyclase-activating polypeptide system as a sex-specific modulator of hippocampal response to threat stimuli. Neurobiology of Stress. 2022; 18DOI:10.1016/j.ynstr.2022.100448. PMID:35685680. IF:5.000(Q2/3D).

Rodriguez, N, Gasso, P, Martinez-Pinteno, A, Segura, AG, Mezquida, G, Moreno-Izco, L, Gonzalez-Penas, J, Zorrilla, I, Martin, M, Rodriguez-Jimenez, R, Corripio, I, Sarro, S, Ibanez, A, Butjosa, A, Contreras, F, Bioque, M, Cuesta, MJ, Parellada, M, Gonzalez-Pinto, A, Berrocoso, E, Bernardo, M, Mas, S, Amoretti, SS, Moren, C, Stella, C, Gurriaran, X, Alonso-Solis, A, Grasa, E, Fernandez, J, Gonzalez-Ortega, I, Casanovas, F, Bulbuena, A, Nunez-Doyle, A, Jimenez-Rodriguez, O, Pomarol-Clotet, E, Feria-Raposo, I, Usall, J, Munoz-Samons, D, Ilundain, JL, Sanchez-Torres, AM, Saiz-Ruiz, J, Lopez-Torres, I, Nacher, J, De-la-Camara, C, Gutierrez, M, Saiz, PA. Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients. SCHIZOPHRENIA. 2022; 8(1)DOI:10.1038/s41537-022-00215-1. PMID:35853879. IF:5.400(Q2/3D).

Martínez-Pinteño A., Mezquida G., Bioque M., López-Ilundain J.M., Andreu-Bernabeu Á., Zorrilla I., Mané A., Rodríguez-Jiménez R., Corripio I., Sarró S., Ibáñez Á., Usall J., Rivero O., Gassó P., Leza J.C., Cuesta M.J., Parellada M., González-Pinto A., Berrocoso E., Mas S., Bernardo M., Amoretti S., Morén C., Urbiola E., González-Peñas J., Roldán A., Catalán A., González-Ortega I., Toll A., Legido T., Sanchez-Pastor L., Dompablo M., Pomarol-Clotet E., R L.-R., Butjosa A., Rubio E., Lorente-OmeñacaR, Ribeiro M., López-Torres I., León-Quismondo L., Nácher J., Contretas F., Lobo A., Gutiérrez-Fraile M., Sáiz P.A.. The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2022; 57DOI:10.1016/j.euroneuro.2022.02.003. PMID:35219096. IF:5.600(Q1/2D).